Kapusta M H, Young-Rodenchuk M, Kourounakis L
J Rheumatol. 1979 Sep-Oct;6(5):507-18.
Adjuvant arthritis is inhibited by the interferon-inducing anti-viral agents statolon, pyran copolymer and tilorone, and by the passive transfer of interferon. The present experiments demonstrate that Virazole, a non-interferon-inducing, anti-viral agent also inhibits adjuvant arthritis. The responses of splenic lymphocytes to phytohemagglutinin and concanavalin A are diminished in active adjuvant disease, due to suppressor cells. Suppressor cells are absent during spontaneous, methodrexate or corticosteroid-induced remissions. Suppressor cells are also absent during Virazole-induced inhibition of adjuvant disease. Methotrexate and corticosteroids inhibit suppressor cells in preference to mitogen-responsive cells in vitro. The preferential inhibition with Virazole is superior to that noted with methotrexate or corticosteroids.
干扰素诱导性抗病毒药物司他洛、吡喃共聚物和泰洛龙以及干扰素的被动转移可抑制佐剂性关节炎。目前的实验表明,一种非干扰素诱导性抗病毒药物病毒唑也能抑制佐剂性关节炎。在活动性佐剂病中,由于抑制细胞的存在,脾淋巴细胞对植物血凝素和刀豆球蛋白A的反应减弱。在自发性、甲氨蝶呤或皮质类固醇诱导的缓解期,抑制细胞不存在。在病毒唑诱导的佐剂病抑制过程中,抑制细胞也不存在。甲氨蝶呤和皮质类固醇在体外优先抑制抑制细胞而非有丝分裂原反应性细胞。病毒唑的优先抑制作用优于甲氨蝶呤或皮质类固醇。